News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ambrose Kristen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 289 shares
@ $329.82, valued at
$95.3k
|
|
| 04/04/2023 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 176 shares
@ $313.74, valued at
$55.2k
|
|
| 02/28/2023 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 502 shares
@ $289.12, valued at
$145.1k
Sold 982 shares
@ $287.25, valued at
$282.1k
Sold 183 shares
@ $288.68, valued at
$52.8k
Sold 42 shares
@ $289.63, valued at
$12.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 60 shares
@ $267.37, valued at
$16k
Sold 80 shares
@ $268.46, valued at
$21.5k
Sold 83 shares
@ $269.51, valued at
$22.4k
Sold 104 shares
@ $271.68, valued at
$28.3k
|
|
| 04/05/2022 |
4
| Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 137 shares
@ $263.09, valued at
$36k
|
|
| 05/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|